Loading...
XTAI
3705
Market cap480mUSD
Dec 05, Last price  
56.40TWD
1D
-1.05%
1Q
-0.70%
Jan 2017
23.55%
IPO
36.56%
Name

YungShin Global Holding Corp

Chart & Performance

D1W1MN
XTAI:3705 chart
P/E
12.86
P/S
1.87
EPS
4.39
Div Yield, %
4.08%
Shrs. gr., 5y
—
Rev. gr., 5y
-0.39%
Revenues
8.03b
+14.29%
2,809,298,0002,962,109,000940,621,0004,079,435,0004,143,011,0004,501,605,0004,702,806,0005,061,661,0005,826,555,0006,034,169,0006,190,862,0006,622,635,0007,513,686,0008,191,531,0008,084,664,0007,805,055,0007,311,769,0007,027,937,0008,031,903,000
Net income
1.17b
+41.24%
722,221,000470,666,000119,604,000524,219,000635,063,000554,130,000444,535,000618,969,000720,058,000893,254,000657,993,000514,056,000701,982,000748,601,000791,720,000736,622,000839,035,000827,304,0001,168,508,000
CFO
1.36b
+14.97%
963,533,000590,064,000128,708,000911,516,000685,209,000356,215,000798,993,0001,193,894,0001,193,596,000556,843,000645,633,000524,555,000953,914,000940,649,0001,227,317,000968,358,000967,245,0001,180,415,0001,357,121,000
Dividend
Jun 24, 20253 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.
URL
http://www.yungshingroup.com/
IPO date
Jan 03, 2011
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT